Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

221 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
When is an oral leukoplakia premalignant?
Sudbø J, Reith A. Sudbø J, et al. Among authors: reith a. Oral Oncol. 2002 Dec;38(8):813-4; author reply 811-2. doi: 10.1016/s1368-8375(02)00021-0. Oral Oncol. 2002. PMID: 12570065 Retracted. No abstract available.
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions.
Sudbø J, Ristimäki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M. Sudbø J, et al. Among authors: reith a. Oral Oncol. 2003 Jul;39(5):497-505. doi: 10.1016/s1368-8375(03)00012-5. Oral Oncol. 2003. PMID: 12747975 Retracted.
The influence of resection and aneuploidy on mortality in oral leukoplakia.
Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. Sudbø J, et al. Among authors: reith a. N Engl J Med. 2004 Apr 1;350(14):1405-13. doi: 10.1056/NEJMoa033374. N Engl J Med. 2004. PMID: 15070790 Retracted.
Molecular based treatment of oral cancer.
Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM. Sudbø J, et al. Among authors: reith a. Oral Oncol. 2003 Dec;39(8):749-58. doi: 10.1016/s1368-8375(03)00098-8. Oral Oncol. 2003. PMID: 13679198 Retracted. Review.
221 results